Published in Am J Physiol Heart Circ Physiol on August 01, 2001
Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes. J Recept Signal Transduct Res (2011) 1.61
Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol (2010) 1.23
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail (2009) 1.13
Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol Rev (2013) 0.96
Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation. J Cardiovasc Pharmacol (2014) 0.96
Adrenergic signaling in heart failure: a balance of toxic and protective effects. Pflugers Arch (2014) 0.94
α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion. Mol Pharmacol (2013) 0.81
When interventions harm. Peer groups and problem behavior. Am Psychol (1999) 7.64
Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med (2001) 4.19
Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem (1997) 3.50
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J Virol (1996) 3.39
Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev (1998) 3.23
Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem (1991) 3.10
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation (1999) 2.38
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation (1999) 2.33
A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem (1996) 2.13
Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J Biol Chem (1986) 2.09
beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. J Biol Chem (1983) 2.07
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A (2001) 1.97
Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem (1991) 1.92
Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem (1988) 1.90
Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. J Biol Chem (1989) 1.88
Peer group dynamics associated with iatrogenic effects in group interventions with high-risk young adolescents. New Dir Child Adolesc Dev (2001) 1.82
Hyperpolarization-activated chloride currents in Xenopus oocytes. J Gen Physiol (1994) 1.80
Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem (1988) 1.75
Phospholemman expression induces a hyperpolarization-activated chloride current in Xenopus oocytes. J Biol Chem (1992) 1.69
Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry (1997) 1.63
Ryanodine: its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharmacol Exp Ther (1979) 1.60
Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol (1997) 1.60
Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res (2001) 1.60
Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A (1994) 1.59
Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem (1991) 1.56
Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem (1999) 1.56
Biochemical evidence for functional heterogeneity of cardiac sarcoplasmic reticulum vesicles. J Biol Chem (1981) 1.54
Rapid purification of calsequestrin from cardiac and skeletal muscle sarcoplasmic reticulum vesicles by Ca2+-dependent elution from phenyl-sepharose. J Biol Chem (1983) 1.53
Phospholamban forms Ca2+-selective channels in lipid bilayers. J Biol Chem (1988) 1.52
Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation (1998) 1.51
Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction. J Biol Chem (2000) 1.51
Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. Biochemistry (1999) 1.50
A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J (1999) 1.50
Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks. Circ Res (1999) 1.49
Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol (2000) 1.49
Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium. J Biol Chem (1999) 1.48
Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem (1995) 1.47
Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits. J Biol Chem (1984) 1.45
Pulsatile hemodynamics in congestive heart failure. Hypertension (2001) 1.44
Unitary anion currents through phospholemman channel molecules. Nature (1995) 1.43
Isolation and partial characterization of rat brain synaptic plasma membranes. J Neurochem (1974) 1.40
Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem (1985) 1.38
Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy. Biochemistry (1995) 1.35
Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem (1997) 1.33
A prospective analysis of dietary energy density at age 5 and 7 years and fatness at 9 years among UK children. Int J Obes (Lond) (2007) 1.33
Biochemical characterization and molecular cloning of cardiac triadin. J Biol Chem (1996) 1.33
Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+. J Biol Chem (1993) 1.32
Biocompatibility aspects of new stent technology. J Am Coll Cardiol (1998) 1.30
Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc Natl Acad Sci U S A (2008) 1.29
Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. J Biol Chem (1978) 1.29
Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities. J Biol Chem (1979) 1.27
Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles. J Biol Chem (1980) 1.26
High molecular weight proteins in cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles bind calmodulin, are phosphorylated, and are degraded by Ca2+-activated protease. J Biol Chem (1984) 1.26
Phospholamban mediates the beta-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes. Am J Physiol (1991) 1.24
Evidence for the presence of phospholamban in the endoplasmic reticulum of smooth muscle. Biochim Biophys Acta (1986) 1.19
Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca(2+)-ATPase. J Biol Chem (1995) 1.19
Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer (2010) 1.18
Regulation of smooth muscle actin-myosin interaction and force by calponin. Acta Physiol Scand (1998) 1.18
Structural alterations in cardiac calcium release units resulting from overexpression of junctin. J Mol Cell Cardiol (2001) 1.18
Smooth muscle protein kinase C. Can J Physiol Pharmacol (1994) 1.18
Response of failing canine and human heart cells to beta 2-adrenergic stimulation. Circulation (1995) 1.18
Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs. Pacing Clin Electrophysiol (1999) 1.16
Protein kinase C mediation of Ca(2+)-independent contractions of vascular smooth muscle. Biochem Cell Biol (1996) 1.16
Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem (2000) 1.15
Ryanodine-induced stimulation of net Ca++ uptake by cardiac sarcoplasmic reticulum vesicles. J Pharmacol Exp Ther (1979) 1.14
Cysteine reactivity and oligomeric structures of phospholamban and its mutants. Biochemistry (1998) 1.14
Rapid preparation of canine cardiac sarcolemmal vesicles by sucrose flotation. Methods Enzymol (1988) 1.13
The physical mechanism of calcium pump regulation in the heart. Biophys J (1994) 1.13
Reexamination of the role of the leucine/isoleucine zipper residues of phospholamban in inhibition of the Ca2+ pump of cardiac sarcoplasmic reticulum. J Biol Chem (2000) 1.13
Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation (1994) 1.12
Modulation of focal and global Ca2+ release in calsequestrin-overexpressing mouse cardiomyocytes. J Physiol (2000) 1.12
Intralumenal sarcoplasmic reticulum Ca(2+)-binding proteins. Semin Cell Biol (1990) 1.12
Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol (2001) 1.11
Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy. Biophys J (2001) 1.11
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. Int J Cardiol (2010) 1.11
Biomechanical modeling of posterior instrumentation of the scoliotic spine. Comput Methods Biomech Biomed Engin (2003) 1.10
Localization of phospholamban in slow but not fast canine skeletal muscle fibers. An immunocytochemical and biochemical study. J Biol Chem (1986) 1.09
Immunoelectron microscopical localization of phospholamban in adult canine ventricular muscle. J Cell Biol (1987) 1.09
Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart (2003) 1.08
Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species. J Mol Cell Cardiol (1999) 1.08
Calponin phosphorylation in vitro and in intact muscle. Biochem J (1993) 1.08
T-tubule localization of the inward-rectifier K(+) channel in mouse ventricular myocytes: a role in K(+) accumulation. J Physiol (2001) 1.06
Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells. J Am Chem Soc (2008) 1.06
Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum. Biochim Biophys Acta (1989) 1.06
Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest (1996) 1.05
Characterization of the intrinsic cAMP-dependent protein kinase activity and endogenous substrates in highly purified cardiac sarcolemmal vesicles. J Biol Chem (1982) 1.04
Smooth-muscle endoplasmic reticulum contains a cardiac-like form of calsequestrin. Biochim Biophys Acta (1987) 1.04
Medical illness in psychiatric patients: barriers to diagnosis and treatment. South Med J (1982) 1.03
GRP94 resides within cardiac sarcoplasmic reticulum vesicles and is phosphorylated by casein kinase II. J Biol Chem (1994) 1.02
Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban. Ann N Y Acad Sci (1998) 1.02
Cardiac-specific phosphorylation site for multifunctional Ca2+/calmodulin-dependent protein kinase is conserved in the brain ryanodine receptor. J Biol Chem (1992) 1.01
Specific binding of the calcium antagonist [3H]nitrendipine to subcellular fractions isolated from canine myocardium. Evidence for high affinity binding to ryanodine-sensitive sarcoplasmic reticulum vesicles. J Biol Chem (1983) 1.01
In vivo regulation of the mouse beta myosin heavy chain gene. J Biol Chem (1994) 1.01
Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase. J Biol Chem (1996) 1.00
Protein kinase C-induced changes in the stoichiometry of ATP binding activate cardiac ATP-sensitive K+ channels. A possible mechanistic link to ischemic preconditioning. Circ Res (1996) 1.00
Phosphorylation-induced structural change in phospholamban and its mutants, detected by intrinsic fluorescence. Biochemistry (1998) 1.00
Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase. J Biol Chem (1992) 1.00